Please login to the form below

Not currently logged in
Email:
Password:

Oxford BioDynamics

This page shows the latest Oxford BioDynamics news and features for those working in and with pharma, biotech and healthcare.

Latest appointments

  • Paul Stockdale joins Oxford BioDynamics as CFO Paul Stockdale joins Oxford BioDynamics as CFO

    Paul Stockdale joins Oxford BioDynamics as CFO. He takes over from Katie Long at the UK biotech. ... A spin-out from Oxford University, Oxford BioDynamics focuses on the discovery and development of epigenetic biomarkers based on regulatory genome

  • Martin Reeves joins Oxford BioDynamics Martin Reeves joins Oxford BioDynamics

    Martin Reeves joins Oxford BioDynamics. He takes up a senior vice president role. ... Oxford BioDynamics – a spin out company from the University of Oxford – has appointed Martin Reeves as its new senior vice president, commercial development.

  • Caldan Therapeutics bolsters senior team Caldan Therapeutics bolsters senior team

    Dr Boyd currently serves as chief financial officer at private life sciences companies Oxford BioDynamics and Enterprise Therapeutics, and was interim-chief financial officer for Tiziana Pharmaceuticals between 2014 and 2015.

More from appointments
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
StratX

StratX creates experiential learning programs instilled with emotion and competitive spirit, leading to lasting on-the-job change. Our memorable approach develops...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics